US FDA Declines to Approve Viatris's Injection for Multiple

The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...

Related Keywords

Bengaluru , Karnataka , India , United States , Pooja Desai , Shinjini Ganguli , Sriparna Roy , Mapi Pharma , Reuters , National Institutes Of Health , Teva Pharmaceutical Industrie , National Institutes , Multiple Sclerosis Ms , S Multiple Sclerosis , Glatiramer Acetate , Brain , Disability , Biologic Therapy , Iologics , Practice Management , Revenue ,